Abate AS Industries posts ₹12.3 crore PAT; revenue jumps 67% on platform scaling

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Abate AS Industries posts ₹12.3 crore PAT; revenue jumps 67% on platform scaling
Overview

Abate AS Industries reported a significant financial turnaround for FY2026, with consolidated revenue rising 67% to ₹161.68 crore and Profit After Tax (PAT) surging to ₹12.3 crore. The company achieved positive operating cash flow for the first time, signaling business model maturity. Management aims to transform into an integrated healthcare platform, targeting 70-80% revenue contribution from healthcare.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Abate AS Industries FY2026: Robust Growth and Healthcare Pivot

Consolidated Revenue: ₹161.68 crore
Profit After Tax (PAT): ₹12.3 crore

Reader Takeaway: Strong revenue growth and positive cash flow mark a turnaround, but working capital management is key.

What just happened

Abate AS Industries has reported a substantial financial leap for FY2026. Consolidated revenue grew by approximately 67% year-on-year to ₹161.68 crore. The company also saw a significant improvement in profitability, with Profit After Tax (PAT) reaching ₹12.3 crore, a tenfold increase from ₹1.1 crore in FY2025. A key milestone was the generation of positive operating cash flow of ₹6.1 crore, marking a validation of the company's business model.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.